Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was $6.31 for the day, down -2.02% from the previous closing price of $6.44. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 3.28 million shares were traded. BCRX stock price reached its highest trading level at $6.43 during the session, while it also had its lowest trading level at $6.13.
Ratios:
Our analysis of BCRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.48 and its Current Ratio is at 3.73.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 30 ’24 when LEVIN ALAN G bought 7,861 shares for $6.36 per share. The transaction valued at 49,996 led to the insider holds 44,951 shares of the business.
ASELAGE STEVE bought 2,500 shares of BCRX for $16,000 on May 24 ’24. The Director now owns 2,500 shares after completing the transaction at $6.40 per share. On May 20 ’24, another insider, MILANO VINCENT, who serves as the Director of the company, bought 15,000 shares for $6.25 each. As a result, the insider paid 93,750 and bolstered with 66,997 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1302238848 and an Enterprise Value of 1818585472. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.66. Its current Enterprise Value per Revenue stands at 5.117 whereas that against EBITDA is -22.155.
Stock Price History:
Over the past 52 weeks, BCRX has reached a high of $8.96, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 19.39%, while the 200-Day Moving Average is calculated to be 8.56%.
Shares Statistics:
BCRX traded an average of 3.65M shares per day over the past three months and 3315190 shares per day over the past ten days. A total of 205.77M shares are outstanding, with a floating share count of 198.11M. Insiders hold about 4.01% of the company’s shares, while institutions hold 86.62% stake in the company. Shares short for BCRX as of 1715731200 were 34352068 with a Short Ratio of 9.42, compared to 1713139200 on 34385237. Therefore, it implies a Short% of Shares Outstanding of 34352068 and a Short% of Float of 16.780001.
